Expert Interviews

Real-time prescription pricing and auto-applied discounts cut pharmacy counter surprises, speed therapy, and free pharmacists for patient-focused care.

Lower patient caps shift costs to community pharmacies, fueling pharmacy benefit manager fees, mail-order growth, and pharmacy deserts.

Pharmacists can review medications that delay wound healing, helping patients choose safer care and avoid infections.

As the “peptide craze” fuels a surge in unregulated vendors, pharmacists must serve as critical navigators to steer patients toward safe, pharmaceutical-grade alternatives.

Nathan Ott, PharmD, discusses the evolution of pharmacists’ role in vaccine administration and how that role has changed since the COVID-19 pandemic and prior.

In an evolving pharmacy landscape, accreditation can be difficult to manage, which is why experts like Mitch Lamb, PharmD, can steer businesses onto their desired paths.

Community pharmacists can spot chronic wound red flags, boost diabetes control, and guide prevention for faster healing and safer care.

Pharmacists cut through wound-care aisle confusion, explaining simple steps, moist healing, and when basic dressings beat pricey ointments.

Sally Rafie, PharmD, BCPS, discusses current developments regarding access to the abortion pill and other notable events regarding women’s reproductive rights.

With a 7-year target date, the FDA is moving away from 10-digit NDCs and toward a universal 12-digit format.

Community pharmacists deliver fast wound assessment, OTC guidance, and prevention tips, supporting safe healing when clinics are closed and care feels urgent.

Community pharmacy workflows can support medical billing and new clinical services, empowering technicians and freeing pharmacists for patient care.

Community pharmacists guide minor wound care—clean, protect, and monitor—spot infection risks, and refer serious injuries quickly to prevent complications.

With workforce and work-life balance issues plaguing pharmacy, the newly introduced hybrid pharmacist role is creating innovation across the greater pharmacy industry.

In part 2 of our interview with Walgreens Chief Pharmacy Officer Rick Gates, he explored the modernization behind his organization’s newly introduced ‘hybrid pharmacist’ role.

An Iowa independent pharmacy runs a cash-pay test‑to‑treat mini clinic, which streamlines workflow and expands patient access fast.

Rick Gates, chief pharmacy officer at Walgreens, helps introduce his organization’s innovative new ‘hybrid pharmacist’ role.

Pharmacists spot diabetes risk early, explain heart- and kidney-protecting meds, decode CGM data, and find affordable support.

Sylvie Stacy, MD, MPH, introduces her work on GLP-1s for addiction and the new pathways this drug class can introduce for patients living with SUD.

Amid recent comments from FDA Commissioner Marty Makary, MD, MPH, that “everything should be OTC,” Mark Garofoli, PharmD, BCGP, CPE, CTTS, helps pharmacists understand what lies ahead.

Gretchen Garofoli, PharmD, BCACP, CTTS, FAPhA, provides her perspective on the back-and-forth stemming from the federal government regarding US vaccine guidelines.

Pharmacists can build trust in buprenorphine care, handle early refill red flags, and point patients to resources to help them with substance use disorder.

Harm reduction for pharmacists can include person-first language and stigma-free naloxone counseling that keeps patients with substance use disorder safer.

Many patients struggle with the everyday realities of staying on the medication, which can include uncomfortable adverse effects.

The SUPPORT Act 2025 lets pharmacists prescribe buprenorphine for opioid use disorder, but DEA training and state rules shape access and new formulations.

Mississippi pharmacies strengthen prenatal care with monthly check-ins, vitamins, aspirin, screenings, and community support for high-risk moms.

Across the United States, trafficking also takes the form of labor exploitation in farms, factories, and remote industrial regions.

With ongoing concerns about the safety and formulation of compounded GLP-1s, Annie Lambert, PharmD, BCSCP, added her expert insights into the recent crackdown of these products.